Key facts
- Nirvana Health’s last known valuation is $70.0M.
- It has raised $38.9M; the latest was Early Stage VC ($24.2M) in Sep 2024.
- Notable investors include Alumni Ventures, Everywhere Ventures, Altos Ventures, Northzone Ventures, NextView Ventures — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Nirvana Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Nirvana Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nirvana Health
Developer of an insurance intelligence platform designed to help therapists manage their finances. The company builds tools that allow care providers across specialties to check coverage from intake through the ongoing management of the patient lifecycle, and provides client billing, payment plans, reimbursement services, finance management, and other tools, enabling therapists to simplify billing and automate insurance checks so that coverage issues do not disrupt patient care.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 47
- Website
- meetnirvana.com/
- Ownership
- Privately Held (backing)
Nirvana Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nirvana Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nirvana Health in its N-PORT filings yet. We sweep new filings monthly.